People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.

Scientists are still trying to wrap their heads around the effects of long COVID, which data shows is affecting more than 1 ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase 3 study.

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

Standiford TJ, Mehrad B, Tsai WC, Moore TA. Pulmonary Host Defenses: The Role of Cytokines in Mediating Lung Inflammation . MedGenMed 1(3), 1999 [formerly published in Medscape Pulmonary Medicine ...

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

A new rat study explores lung function and placental changes in the presence of infection and inflammation. The study ...

Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in ...

Inhibiting GLS1 reduced high blood pressure in the right side of the heart of PAH rats and improved various measures of heart ...